Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Trinity Biotech (TRIB) Assets Average (2016 - 2025)

Trinity Biotech's Assets Average history spans 17 years, with the latest figure at $102.4 million for Q4 2025.

  • On a quarterly basis, Assets Average rose 2.02% to $102.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $102.4 million, a 2.02% increase, with the full-year FY2025 number at $104.2 million, up 28.1% from a year prior.
  • Assets Average hit $102.4 million in Q4 2025 for Trinity Biotech, up from $101.5 million in the prior quarter.
  • Over the last five years, Assets Average for TRIB hit a ceiling of $133.2 million in Q1 2021 and a floor of $61.5 million in Q4 2023.
  • Historically, Assets Average has averaged $99.7 million across 5 years, with a median of $100.9 million in 2024.
  • Biggest five-year swings in Assets Average: crashed 35.25% in 2023 and later surged 63.16% in 2024.
  • Tracing TRIB's Assets Average over 5 years: stood at $120.8 million in 2021, then decreased by 21.38% to $95.0 million in 2022, then tumbled by 35.25% to $61.5 million in 2023, then skyrocketed by 63.16% to $100.4 million in 2024, then grew by 2.02% to $102.4 million in 2025.
  • Business Quant data shows Assets Average for TRIB at $102.4 million in Q4 2025, $101.5 million in Q2 2025, and $100.4 million in Q4 2024.